Overview

Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the present study was to compare the effectiveness of the different oral iron preparations in children with IDA.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hacettepe University
Treatments:
Glycine
Iron
Zinc
Criteria
Inclusion Criteria:

- The children with IDA, aged between 6 months and 15 years, were randomly included in
Fe-S (Ferro Sanol® sp.)(Group I), Fe-OH-PM (Santafer® sp.)(Group II), and Fe-Zn (Ferro
Zinc® sp.)(Group III). IDA was defined as hemoglobin (Hgb), serum iron and ferritin
levels below -2SD according to age and gender.

Exclusion Criteria:

- The main exclusion criteria were anemia due to other causes except IDA

- Severe concurrent illness (cardiovascular, renal, and hepatic)

- Known hypersensitivity to ferrous or ferric preparations

- Malignancy of any type

- Children with thalassemia major, sickle cell anemia or other hemoglobinopathies,
hemolytic anemia or aplastic or hypoplastic anemia.